| Prev Close | 110.99 |
| Open | 111.45 |
| Day Low/High | 109.43 / 111.56 |
| 52 Wk Low/High | 75.39 / 111.75 |
| Volume | 7.71M |
| Avg Volume | 7.20M |
Procter & Gamble Co. (PG)
109.60
1.39
1.25
NYSE : Consumer Non-Durables
| Exchange | NYSE |
| Shares Outstanding | 2.51B |
| Market Cap | 278.93B |
| EPS | 3.80 |
| P/E Ratio | 26.41 |
| Div & Yield | 2.98 (2.61%) |
Latest News
Water Company Dividend Kings That Quench the Thirst for Income
Dividend stock investors should look to have at least some exposure to this sector.
The Nasdaq A/D Line Peaked Months Ago: Danger Will Robinson
'It is not a healthy market when the generals are still going up and the troops are in retreat.'
Jim Cramer: The Forbidden City of Stock Sectors
Now, we know that if we got any sort of truce in the trade war, with the exception of the financials, these hated sectors would be loved.
Jim Cramer: A Surprisingly Predictable Selloff
If these are going to define the day then we really are in silly land.
3 Consumer Staples Stocks for a Volatile Market
It might not be a bad idea to move toward some conservative names such as PG, MDLZ and PEP.
Trade Talks Disintegrate, Apple Antitrust and Defensive Moves
Movement into defensive names should be considered a sign of caution.
Jim Cramer: What Should People Be Doing?
There's just no reason to be aggressive.
Jim Cramer: U.S. Companies Are Ready for China Tariffs
Only economists and pundits seem to be worried about a pending crash that might never occur.
Jim Cramer: Sometimes It Takes a Really Hideous Tape to Find Some Winners
If you can survive this hell week you can pretty much survive anything.
Jim Cramer: It Isn't a Slowdown That I Fear, It's a Tweet
This is the first time I can ever recall when a president is so attuned to the market that he will bend to its wishes.
Jim Cramer: What to Buy and What to Avoid on Trump's Latest China Tweet
As usual, the stocks that bounce back first are the tech stocks with little Chinese exposure and the consumer packaged goods that just demonstrated good numbers.
Jim Cramer: It's Stupid Is as Stupid Does on a Ridiculous Day in the Market
Portfolio managers are exercising their First Amendment right to do incredibly stupid things.
Procter & Gamble or Kimberly-Clark? Why One Dividend Aristocrat Has the Edge
The advantage goes to P&G as the larger of the two behemoths in consumer staples has been posting stronger results of late.
Today's Trades (and Observations)
* I plan to continue to short all gaps higher While month end lies ahead (in only a few days), I don't view today's action as too sporty and sustainable: * Both the S&P and Russell Index appear about to drop below their opening prints - the has alre...
Jim Cramer: Blockbuster Ideas That I Know Would Move Apple's Needle
What would the people who help determine AAPL's stock price really want?
How to Play the Fed's Gift to the Markets (One Way Is With Netflix)
Wednesday was the first day that Netflix traded on above-average volume since Jan. 24.
Digging Down on the Dow 30
Just 13 of the 30 Dow components are in clear uptrends.
Jim Cramer: AAPL Should Get Into Diabetes Treatment and KHC Should Invest in Pot
In this day and age, companies must be 'disruptors' or get left in the dust.
I Would Not Pay Up for Aurora Cannabis
* Nelson Peltz's imprimatur has value * But, from my perch, not $1 billion of value! "Buy Aurora Cannabis . Buy it because Nelson Peltz is now an advisor to the company with options to buy 20 million shares at a minimum. Buy it because Nelson's con...
Aurora Cannabis' Is a Beast but the Stock Has Entered a Tricky Area Now
Aurora Cannabis' hiring of deal maker Nelson Peltz opens up a wealth of new possibilities for the Canadian pot company.
Buy Levels
Here are some of my individual buy levels of stocks that I want to add to or reestablish on weakness: * $157.50 * $1625 * $1150 * $42 * $55 * $46 * $46.50 * $182.50 * $31 * $40 * $23 * $65 * $16.75 * $35 * $27.75 * $60 * $95 * $48 * $87.50 Note: Lon...
Jim Cramer: Buy Aurora Cannabis Because Nelson Peltz Knows What Can Go Right
I know that Nelson is fascinated by the medicinal properties chiefly as a replacement for opioids, the scourge of this country.
Nelson Peltz Could Be Key to Cannabis in Consumer Packaged Goods
Aurora's prominent partner could be cannabis' key to breaking into consumer segments.
Aurora Cannabis Builds Momentum, Enter Nelson Peltz
The plan is for Peltz to help the firm in maximizing potential markets to target.
Aurora Cannabis Stock Burns Higher After Adding Billionaire Advisor Peltz
Aurora's addition of a big name activist is accelerating share growth.
In the Lull Between Earnings Seasons, Keep an Eye on Insider Selling
A key data point to watch, now that corporate blackout dates have come and gone, is insider selling activity.
